SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Aurobindo Pharm
Aurobindo Pharm
BSE: 524804NSE: AUROPHARMAISIN: INE406A01037

22nd-Nov-2012 11:36Source: BSE

Aurobindo Pharm - Aurobindo Pharma appoints Mr. Arvind Vasudeva as Chief Executive Officer (Formulations)

Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated November 22, 2012, titled "Aurobindo Pharma appoints Mr. Arvind Vasudeva as Chief Executive Officer (Formulations)."

More Announcements on:

22nd-Dec-2014 17:40Source: NSE

Aurobindo Pharma Limited

22nd-Dec-2014 17:39Source: NSE

Aurobindo Pharma Limited

11th-Dec-2014 08:36Source: BSE

Aurobindo Pharm - Outcome of Board Meeting

5th-Dec-2014 16:08Source: NSE

Aurobindo Pharma Limited

25th-Nov-2014 21:50Source: BSE

Aurobindo Pharm - Outcome of Board Meeting

25th-Nov-2014 19:00Source: NSE

Aurobindo Pharma Limited

21st-Nov-2014 17:14Source: BSE

Aurobindo Pharm - Board Meeting on Nov 25, 2014

18th-Nov-2014 15:20Source: NSE

Aurobindo Pharma Limited

1 2 3 4 5 Next >>
OUR WINNING PICKS

DID YOU INVEST?

INTRADAY PICKS!

(December 22, 2014)

AT (Rs)



GAIN (Rs)

ALL TIME WINNERS

RECO PRICE

PEAK PRICE

OUR PACKAGES

Super Combo
2400

Powerful mix of both trader and investor packs with timely expert advice.

Technical
1429

Designed especially for traders looking to tap the profit opportunities of volatile markets.

Fundamental
1429

For all investors looking to unearth stocks that are poised to move.

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.